These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16079867)

  • 1. Killing pain, not neurons.
    Sahagan BG; Stephenson DT; Hounslow N; Liston DR; Manning PT
    Nat Med; 2005 Aug; 11(8):817-8. PubMed ID: 16079867
    [No Abstract]   [Full Text] [Related]  

  • 2. NSAIDS for prevention? Protecting the brain while killing pain?
    Helmuth L
    Science; 2002 Aug; 297(5585):1262-3. PubMed ID: 12193765
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
    Ferrera P; Arias C
    Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 6. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
    Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
    J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory drugs fall short in Alzheimer's disease.
    Nat Med; 2008 Sep; 14(9):916. PubMed ID: 18776882
    [No Abstract]   [Full Text] [Related]  

  • 9. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
    Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
    Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL
    Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators.
    Narlawar R; Pérez Revuelta BI; Haass C; Steiner H; Schmidt B; Baumann K
    J Med Chem; 2006 Dec; 49(26):7588-91. PubMed ID: 17181139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
    Kapoor S; Bahde R
    Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production.
    Gamerdinger M; Clement AB; Behl C
    Mol Pharmacol; 2007 Jul; 72(1):141-51. PubMed ID: 17395689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New presenilin 1 mutation with Alzheimer disease and Lewy bodies.
    Rosenberg RN
    Arch Neurol; 2005 Dec; 62(12):1808. PubMed ID: 16344337
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.
    Mi WL; Mao-Ying QL; Liu Q; Wang XW; Wang YQ; Wu GC
    Brain Res Bull; 2008 Sep; 77(2-3):98-104. PubMed ID: 18721668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.